Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-015333
Filing Date
2020-06-04
Accepted
2020-06-04 21:06:24
Documents
1
Period of Report
2020-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3935
  Complete submission text file 0000899243-20-015333.txt   5327
Mailing Address C/O IDM PHARMA, INC. 9 PARKER, SUITE 100 IRVINE CA 92618
Business Address
SHERMAN JEFFREY W (Reporting) CIK: 0001230482 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38536 | Film No.: 20944306

Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Issuer) CIK: 0001346302 (see all company filings)

EIN.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations